Re: Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy, et al. First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin. Eur Urol. 2022;82:602-10

Eur Urol. 2023 Feb;83(2):e54-e55. doi: 10.1016/j.eururo.2022.10.025. Epub 2022 Nov 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adjuvants, Immunologic / therapeutic use
  • Administration, Intravesical
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • BCG Vaccine* / therapeutic use
  • Humans
  • Neoplasm Recurrence, Local
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • pembrolizumab
  • BCG Vaccine
  • Antibodies, Monoclonal, Humanized
  • Adjuvants, Immunologic